Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity
Year: 2020
Type: review
Source: Blood Reviews
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W3041361317
